Intravenous diacetylmorphine (heroin) in studies of opiate dependence.
D001952:Bridged-Ring Compounds / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003496:Cyclazocine / Q000008:administration & dosage; D004569:Electroencephalography; D005625:Frontal Lobe / Q000502:physiology; D005663:Furans / Q000008:administration & dosage; D003932:Heroin / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D006801:Humans; D007275:Injections, Intravenous; D007659:Ketones / Q000008:administration & dosage; D008297:Male; D008691:Methadone / Q000008:administration & dosage; D009021:Morphine Dependence / Q000188:drug therapy*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009778:Occipital Lobe / Q000502:physiology; D010616:Phenanthrenes / Q000008:administration & dosage; D012640:Seizures / Q000139:chemically induced
D001952:Bridged-Ring Compounds; D005663:Furans; D007659:Ketones; D009292:Narcotic Antagonists; D010616:Phenanthrenes; D003932:Heroin; D003496:Cyclazocine; D008691:Methadone